William Monroe

Dr. William Monroe

orcid

Research Focus & Metrics

Academic Career Length

24Years (2003-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 September 2007 in Journal of Photochemistry and Photobiology B: Biology
Verified
Journal Article
Closed access
QDQiaoxiang Dong
Qiaoxiang Dong
KSKurt Svoboda
Kurt Svoboda
TTTerrence R. Tiersch
Terrence R. Tiersch
WMWilliam Monroe
William Monroe

31 March 2008 in Molecular BioSystems
Verified
Journal Article
Closed access
PDF file
RBRichard A Blidner
Richard A Blidner
KSKurt R. Svoboda
Kurt R. Svoboda
RHRobert P. Hammer
Robert P. Hammer
WMWilliam Monroe
William Monroe
Various chemical modifications to RNA have been incorporated in attempts to improve their pharmacological properties for RNAi interference (RNAi). Recent studies have shown that small interfering RNA (siRNA) containing 2′-fluoro modifications can elicit gene silencing through RNAi. Despite developments in using chemical modifications for increased stability, safety, and efficiency of these therapeutics, they still face challenges of spatial and temporal targeting. One potential targeting strategy is to use photocaging techniques, which involve the covalent attachment of photolabile compounds to the effector nucleic acid species that block bioactivity until exposed to near UV light. In this study we demonstrate that fully 2′-fluorinated nucleic acids (FNAs) can be caged for photoactivated gene silencing in cell culture and in zebrafish embryos. This strategy combines the improvement in chemical and enzymatic stability associated with 2′-substitutions with the targeting ability of a photoinducible trigger. Statistical alkylation of FNAs with 1-(4,5-dimethoxy-2-nitrophenyl)diazoethane (DMNPE) improved resistance to enzymatic degradation, reduced RNAi effectiveness, and protected the biological system from toxic doses of the effector. Photo-exposure to 365 nm light partially restored the silencing activity of the 2′-fluoro siRNAs. These results suggest that photocaging may offer control over RNAi therapeutics for spatially and temporally directed activation, while improving enzymatic stability and potentially enabling therapeutic dosing via light dose intensity.

16 April 2012 in Journal of Micromechanics and Microengineering
Verified
Journal Article
Closed access
Thomas Foster ScherrThomas Foster Scherr
Thomas Foster Scherr
CQChristian Quitadamo
Christian Quitadamo
PTPreston Tesvich
Preston Tesvich
DPDaniel Sang-Won Park
Daniel Sang-Won Park
TTTerrence Tiersch
Terrence Tiersch
WMWilliam Monroe
William Monroe
A passive, planar micromixer design based on logarithmic spirals is presented. The device was fabricated using polydimethylsiloxane soft photolithography techniques, and mixing performance was characterized via numerical simulation and fluorescent microscopy. Mixing efficiency initially declined as Reynolds number increased, and this trend continued until a Reynolds number of 15 where a minimum was reached at 53%. Mixing efficiency then began to increase reaching a maximum mixing efficiency of 86% at Re = 67. Three-dimensional simulations of fluid mixing in this design were compared to other planar geometries such as the Archimedes spiral and Meandering-S mixers. The implementation of logarithmic curvature offers several unique advantages that enhance mixing, namely a variable cross-sectional area and a logarithmically varying radius of curvature that creates 3-D Dean vortices. These flow phenomena were observed in simulations with multilayered fluid folding and validated with confocal microscopy. This design provides improved mixing performance over a broader range of Reynolds numbers than other reported planar mixers, all while avoiding external force fields, more complicated fabrication processes, and the introduction of flow obstructions or cavities that may unintentionally affect sensitive or particulate-containing samples. Due to the planar design requiring only single-step lithographic features, this compact geometry could be easily implemented into existing micro-total analysis systems requiring effective rapid mixing.


6 February 2007 in Photochemical & Photobiological Sciences
Verified
Journal Article
Closed access
PDF file
JFJulianne Forman
Julianne Forman
MDMarilyn Dietrich
Marilyn Dietrich
WMWilliam Monroe
William Monroe
While near-ultraviolet light has been widely used to photoactivate fluorophores and caged compounds in cells, little is known of the long-term biological effects of this light. UVA (315–400 nm) photoactivating light has been well characterized in short-term cell studies and is now being employed in higher doses to control longer-duration phenomena (e.g. gene expression). Annexin V-Cy5/propidium iodide apoptosis flow cytometry assays were used to determine responses of HeLa cells to doses of UVA light up to 23.85 J cm–2. Cells seeded at low densities had higher percentages of apoptosis and necrosis and were also more susceptible to UVA damage than cells seeded at higher densities. The dose to induce apoptosis and death in 50% of the cells (dose1/2) was determined for two different commercially available UVA light sources: 7.6 J cm–2 for the GreenSpot photocuring system and 2.52 J cm–2 for the BlakRay lamp. All BlakRay doses tested had significant cellular responses, whereas no significant cellular responses were found for doses below 1.6 J cm–2 from the GreenSpot light source. A temperature control and measurement system was used to determine direct heating from the UVA sources and also the effect that cooling cell cultures during photoexposure has on minimizing cell damage. Cooling during the BlakRay photoexposure significantly reduced the percentage of necrotic cells, but there was no significant difference for cooling during photoactivation with the GreenSpot. Differences in cell responses to similar UVA doses of different intensities suggest that photoduration should be considered along with total dose and thermal conditions in photoactivation studies.

26 July 2007 in Chemical Biology & Drug Design
Verified
Journal Article
Closed access
PDF file
RBRichard A. Blidner
Richard A. Blidner
RHRobert P. Hammer
Robert P. Hammer
TTTakashi Taguchi
Takashi Taguchi
SRSandra O. Robinson
Sandra O. Robinson
WMWilliam Monroe
William Monroe